Consumers and health professionals are advised that there is a shortage of oral contraceptive pills containing the combination ethinylestradiol and norethisterone. The affected products are:
- Brevinor – norethisterone 0.5 mg and ethinylestradiol 35 micrograms
- Norimin – norethisterone 0.5 mg and ethinylestradiol 35 micrograms
- Brevinor-1 – norethisterone 1 mg and ethinylestradiol 35 micrograms
- Norimin-1 – norethisterone 1 mg and ethinylestradiol 35 micrograms.
All four products are sponsored by Pfizer Australia Pty Ltd.
/Public Release. The material in this public release comes from the originating organization and may be of a point-in-time nature, edited for clarity, style and length. View in full here.
